elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27027762-84B6AE7C-AB2F-442D-B056-C8D67FE6C387
Q27027762-84B6AE7C-AB2F-442D-B056-C8D67FE6C387
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27027762-84B6AE7C-AB2F-442D-B056-C8D67FE6C387
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
P2860
Q27027762-84B6AE7C-AB2F-442D-B056-C8D67FE6C387
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27027762-84B6AE7C-AB2F-442D-B056-C8D67FE6C387
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef434a79769630503fdff60cd277f371a38e770e
P2860
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.